Estrogens protect myocardium against ischemia/reperfusion insult by up-regulation of CRH receptor type 2 in female rats

International Journal of Cardiology

Volumn 168, Issue 5, 2013, Pages 4755-4760

  Cong, Binhai ^a   Zhu, Xiaoyan ^a   Cao, Buqing ^a   Xiao, Jian ^b   Wang, Zhinong ^b   Ni, Xin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Corticotropin releasing hormone receptors; Epigenetic; Estrogen; Methylation; Myocardium

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; CREATINE KINASE; ESTRADIOL; ESTROGEN; LACTATE DEHYDROGENASE; MESSENGER RNA; UROCORTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CRHR2 GENE; DNA METHYLATION; FEMALE; GENE; HEART INFARCTION SIZE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; LACTATE DEHYDROGENASE BLOOD LEVEL; NICK END LABELING; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REPERFUSION INJURY; SHAM PROCEDURE;

CORTICOTROPIN-RELEASING HORMONE RECEPTORS; EPIGENETIC; ESTROGEN; METHYLATION; MYOCARDIUM;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; IN SITU NICK-END LABELING; INJECTIONS, SUBCUTANEOUS; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RNA, MESSENGER; UROCORTINS;

EID: 84886421412     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.07.231     Document Type: Article

References (35)

1. C.G. Isles, D.J. Hole, V.M. Hawthorne, and A.F. Lever Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey: comparison with men Lancet 339 1992 702 706
2. M. Mendelsohn, and R. Karas Molecular and cellular basis of cardiovascular gender differences Science 308 2005 1583 1586
3. E. Barrett-Connor, and T.L. Bush Estrogen and coronary heart disease in women JAMA 265 1991 1861 1867
4. C.E. Davis, A. Pajak, and S. Rywik Natural menopause and cardiovascular disease risk factors. The Poland and US collaborative study on cardiovascular disease epidemiology Ann Epidemiol 4 1994 445 448
5. M.G. Shlipak, B.G. Angeja, A.S. Go, P.D. Frederick, J.G. Canto, and D. Grady Hormone therapy and in-hospital survival after myocardial infarction in postmenopausal women Circulation 104 2001 2300 2304
6. K.M. Newton, A.Z. LaCroix, and B. McKnight Estrogen replacement therapy and prognosis after first myocardial infarction Am J Epidemiol 145 1997 269 277
7. H. Liu, A. Pedram, and J.K. Kim Oestrogen prevents cardiomyocyte apoptosis by suppressing p38α-mediated activation of p53 and by down-regulating p53 inhibition on p38β Cardiovasc Res 89 2011 119 128
8. T. Shinohara, N. Takahashi, T. Ooie, M. Ichinose, M. Hara, and H. Yonemochi Estrogen inhibits hyperthermia-induced expression of heat-shock protein 72 and cardioprotection against hypoxia/reperfusion injury in female rat heart J Mol Cell Cardiol 37 2004 1053 1061
9. R.D. Patten, I. Pourati, and M.J. Aronovitz 17β-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling Circ Res 95 2004 692 699
10. D. Grady, D. Herrington, and V. Bittner Cardiovascular disease outcomes during 6.8 years of hormone therapy: heart and estrogen/progestin replacement study follow-up (HERS II) JAMA 288 2002 49 57
11. H.N. Hodis, W.J. Mack, and S.P. Azen Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women N Engl J Med 349 2003 535 545
12. P. Boonprasert, N. Lailerd, and N. Chattipakorn Urocortins in heart failure and ischemic heart disease Int J Cardiol 127 3 2008 307 312
13. B.K. Brar, A. Stephanou, and A. Okosi CRH-like peptides protect cardiac myocytes from lethal ischaemic injury Mol Cell Endocrinol 158 1999 55 63
14. B.K. Brar, A.K. Jonassen, and A. Stephanou UCN protects against ischemic and reperfusion injury via a MAPK-dependent pathway J Biol Chem 275 2000 8508 8514
15. A.K. Jonassen, A. Wergeland, E. Helgeland, O.D. Mjøs, and B.K. Brar Activation of corticotrophin releasing factor receptor type 2 in the heart by corticotropin releasing factor offers cytoprotection against ischemic injury via PKA and PKC dependent signaling Regul Pept 174 1-3 2012 90 97
16. B.K. Brar, A. Stephanou, R. Knight, and D.S. Latchman Activation of protein kinase B/Akt by UCN is essential for its ability to protect cardiomyocytess against hypoxia/reoxygenation-induced cell death J Mol Cell Cardiol 34 2002 483 492
17. T. Smani, E. Calderón-Sanchez, and N. Gómez-Hurtado Mechanisms underlying the activation of L-type calcium channels by urocortin in rat ventricular myocytes Cardiovasc Res 87 3 2010 459 466
18. K.M. Lawrence, T.M. Scarabelli, and L. Turtle UCN protects cardiac myocytes from I/R injury by attenuating calcium-insensitive phospholipase A2 gene expression FASEB J 17 2003 2313 2315
19. R.A. Knight, C. Chen-Scarabelli, and Z. Yuan Cardiac release of UCN precedes the occurrence of irreversible myocardial damage in the rat heart exposed to I/R injury FEBS Lett 582 6 2008 984 990
20. C.J. Lagranha, A. Deschamps, A. Aponte, C. Steenbergen, and E. Murphy Sex difference in the phosphorylation of mitochondrial proteins result in reduced production of reactive oxygen species and cardioprotection in females Circ Res 106 2010 1681 1691
21. K.L. Hamilton, L. Lin, Y. Wang, and A.A. Knowlton Effect of ovariectomy on cardiac gene expression: inflammation and changes in SOCS genes expression Physiol Genomics 32 2007 254 263
22. P. Haeger, M.E. Andrés, M.I. Forray, C. Daza, S. Araneda, and K. Gysling Estrogen receptors alpha and beta differentially regulated the transcriptional activity of the UCN gene J Neurosci 26 18 2006 4908 4916
23. K.P. Singh, J. Treas, T. Tyagi, and W. Gao DNA demethylation by 5-aza-2-deoxycytidine treatment abrogates 17 beta-estradiol-induced cell growth and restores expression of DNA repair genes in human breast cancer cells Cancer Lett 316 1 2012 62 69
24. J. Tomikawa, Y. Uenoyama, and M. Ozawa Epigenetic regulation of Kiss1 gene expression mediating estrogen-positive feedback action in the mouse brain PNAS 109 20 2012 1294 1301
25. H.L. Jeanes, C. Tabor, D. Black, A. Ederveen, and G.A. Gray Oestrogen-mediated cardioprotection following ischaemia and reperfusion is mimicked by an oestrogen receptor (ER)α agonist and unaffected by an ERβ antagonist J Endocrinol 197 2008 493 501
26. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 25 4 2001 402 408
27. J.M. Ordovás, and C.E. Smith Epigenetics and cardiovascular disease Nat Rev Cardiol 7 9 2010 510 519
28. P.A. Jones, and D. Takai The role of DNA methylation in mammalian epigenetics Science 293 2001 1068 1070
29. D.J. Hausenloy, and D.M. Yellon Cardioprotective growth factors Cardiovasc Res 83 2 2009 179 194
30. S.C. Coste, K.A. Heldwein, S.L. Stevens, E. Tobar-Dupres, and M.P. Stenzel-Poore IL-1alpha and TNFalpha down-regulate CRH receptor-2 mRNA expression in the mouse heart Endocrinology 142 8 2001 3537 3545
31. S. Wang, X. Zhu, B. Cong, X. You, Y. Wang, W. Wang, and X. Ni Estrogenic action on arterial smooth muscle: permissive for maintenance of CRHR2 expression Endocrinology 153 4 2012 1915 1924
32. M. Akerfelt, R.I. Morimoto, and L. Sistonen Heat shock factors: integrators of cell stress, development and lifespan Nat Rev Mol Cell Biol 11 2010 545 555
33. G. Fujii, Y. Nakamura, D. Tsukamoto, M. Ito, T. Shiba, and N. Takamatsu CpG methylation at the USF-binding site is important for the liver-specific transcription of the chipmunk HP-27 gene Biochem J 395 2006 203 209
34. S. Wassertheil-Smoller, S.L. Hendrix, and M. Limacher Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial JAMA 289 2003 2673 2684
35. P.H. Gann, and M. Morrow Combined hormone therapy and breast cancer: a single-edged sword JAMA 289 2003 3304 3306